Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Gerontol Geriatr ; 58(2): 293-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24238886

RESUMO

Mussel bioactive peptides have been viewed as mediators to maximize the high quality of life. In this study, the anti-aging activities of mussel oligopeptides were evaluated using H2O2-induced prematurely senescent MRC-5 fibroblasts. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry displayed that exposure to H2O2 led to the loss of cell viability and cell cycle arrest. In addition, H2O2 caused the elevation of senescence-associated-ß-galactosidase (SA-ß-gal) activity and formation of senescence-associated heterochromatin foci (SAHF). It was found that pretreatment with mussel oligopeptides could significantly attenuate these properties associated with cellular senescence. Mussel oligopeptides also led to the increase of glutathione (GSH) level and mitochondrial transmembrane potential (Δψm) recovery. In addition, mussel oligopeptides resulted in an improvement in transcriptional activity of peroxiredoxin 1 (Prx1), nicotinamide phosphoribosyltransferase (NAMPT) and sirtuin 1 (SIRT1). This study revealed that mussel oligopeptides could protect against cellular senescence induced by H2O2, and the effects were closely associated with redox cycle modulating and potentiating the SIRT1 pathway. These findings provide new insights into the beneficial role of mussel bioactive peptides on retarding senescence process.


Assuntos
Ciclo Celular/fisiologia , Senescência Celular/fisiologia , Fibroblastos/enzimologia , Peróxido de Hidrogênio/farmacologia , Oligopeptídeos/metabolismo , Oxidantes/farmacologia , Envelhecimento , Animais , Bivalves , Ciclo Celular/efeitos dos fármacos , Senescência Celular/efeitos dos fármacos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fibroblastos/patologia , Humanos , Peróxido de Hidrogênio/metabolismo , Oligopeptídeos/farmacologia , Oxidantes/metabolismo , Peroxirredoxinas , Conformação Proteica , Sirtuína 1/metabolismo , Sais de Tetrazólio , Tiazóis , beta-Galactosidase/metabolismo
2.
Food Chem Toxicol ; 59: 412-20, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23796539

RESUMO

Dietary supplementation exerts beneficial effects in reducing incidence of chronic neurodegenerative diseases. The purpose of this study was to examine protective effects of mussel (Mytilus edulis) oligopeptides supplementation on brain function in D-galactose induced aging mice. Sixty female 8-month-old mice were randomly divided into five groups: vehicle control, D-galactose, and D-galactose combined with 200, 500, 1000 mg/kg mussel oligopeptides. The results showed that mussel oligopeptides could improve cognitive learning and memory ability and protect the hippocampal neurons. In addition, GSH, SOD and GSH-pX activities were increased and MDA level was significantly decreased in mice fed with mussel oligopeptides. It was also found that mussel oligopeptides supplementation prevented D-galactose-induced elevations of iNOS activity and NO production and lactate acid levels in brain. Moreover, PI3K and Akt genes were up-regulated by mussel oligopeptides supplementation. These findings suggest that mussel oligopeptides are able to enhance exercise capacity and protect against oxidative damage caused by D-galactose in aging model mice through regulating oxidation metabolism and PI3K/Akt/NOS signal pathway. Therefore, mussel oligopeptides are good materials for future development of healthcare products to combat age-related brain dysfunction and to improve healthy life span.


Assuntos
Envelhecimento , Região CA1 Hipocampal/metabolismo , Transtornos Cognitivos/prevenção & controle , Modelos Animais de Doenças , Mytilus edulis/metabolismo , Nootrópicos/uso terapêutico , Oligopeptídeos/uso terapêutico , Animais , Comportamento Animal , Região CA1 Hipocampal/enzimologia , Região CA1 Hipocampal/patologia , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/patologia , Proteínas Alimentares/administração & dosagem , Proteínas Alimentares/isolamento & purificação , Proteínas Alimentares/uso terapêutico , Suplementos Nutricionais , Feminino , Galactose , Peroxidação de Lipídeos , Camundongos , Camundongos Endogâmicos ICR , Proteínas do Tecido Nervoso/metabolismo , Neurônios/enzimologia , Neurônios/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/isolamento & purificação , Fármacos Neuroprotetores/uso terapêutico , Nootrópicos/administração & dosagem , Nootrópicos/isolamento & purificação , Oligopeptídeos/administração & dosagem , Oligopeptídeos/isolamento & purificação , Estresse Oxidativo , Distribuição Aleatória , Frutos do Mar/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA